Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR4F17 Inhibitors

OR4F17, part of the olfactory receptor gene family, is primarily expressed in olfactory epithelial tissues, where it plays a critical role in the detection and discrimination of airborne molecules. As a G protein-coupled receptor (GPCR), its function is to bind specific odorant molecules in the nasal cavity, initiating a signal transduction pathway that results in the perception of smell. This process is essential for various behaviors, including food selection, predator avoidance, and social communication among species. The specificity and sensitivity of OR4F17 to certain odorants suggest its evolutionary adaptation to detect compounds of ecological and physiological relevance. The inhibition of OR4F17, like other olfactory receptors, involves mechanisms that reduce its ability to participate in or initiate the aforementioned signal transduction pathways. One primary mode of inhibition can be the competitive binding of antagonistic molecules that structurally mimic the natural ligands of OR4F17 but do not activate the receptor. These antagonists effectively block the binding site of the receptor, preventing activation by the natural odorant and thereby silencing the receptor's signaling ability. Another mechanism could involve changes in the receptor's expression levels, which can be modulated by genetic or epigenetic factors, reducing the number of functional receptors available for interaction with odorants. Furthermore, post-translational modifications such as phosphorylation can also regulate the activity of OR4F17 by altering receptor conformation or facilitating its internalization from the cell surface, thus decreasing its availability and responsiveness to odorants. These mechanisms ensure the precise control of olfactory signaling, which is crucial for maintaining the balance and appropriateness of sensory input.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Phosphodiesterase inhibitor that raises intracellular cAMP levels, potentially altering OR4F17 signaling by modulating downstream effectors.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor, can indirectly modulate G-protein coupled receptor (GPCR) signaling pathways where OR4F17 may be implicated.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

Inhibits PKC, which could be involved in OR4F17 signaling cascades, modulating downstream response.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Tyrosine kinase inhibitor can indirectly affect OR4F17-mediated cellular responses by inhibiting downstream signal transduction.

SQ 22536

17318-31-9sc-201572
sc-201572A
5 mg
25 mg
$93.00
$356.00
13
(1)

An adenylate cyclase inhibitor, potentially inhibits the conversion of ATP to cAMP, which is a part of OR4F17 signaling.

Chelerythrine

34316-15-9sc-507380
100 mg
$540.00
(0)

A potent PKC inhibitor that can disrupt OR4F17 downstream signaling pathways involving PKC.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Rho kinase inhibitor can affect cytoskeletal changes, indirectly altering OR4F17-mediated cellular signaling.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

Calcium chelator that can inhibit calcium-dependent processes associated with OR4F17 signaling.

KN-93

139298-40-1sc-202199
1 mg
$178.00
25
(1)

Calmodulin-dependent protein kinase II (CaMKII) inhibitor that can influence OR4F17-mediated intracellular calcium levels.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that can disrupt MAPK/ERK signaling pathways linked to OR4F17 activation.